Manning & Napier Advisors LLC Purchases New Stake in The Cooper Companies, Inc. $COO

Key Points

• Manning & Napier Advisors purchased 1.51 million Cooper Companies shares worth approximately $107.9 million, giving it a 0.77% stake and making COO about 1.4% of its portfolio. Institutional ownership overall stands at 24.39%.
• Cooper Companies reported quarterly EPS of $1.21, beating estimates by $0.11, while revenue rose 7.9% year over year to $1.08 billion. The company’s fiscal 2026 EPS guidance is $4.58–$4.66.
• COO opened at $75.80, below the analyst consensus target of $81.64. Analyst sentiment is mixed, with an overall “Hold” rating, including recent price-target cuts and sell ratings from Wells Fargo and Weiss Ratings.

Manning & Napier Advisors LLC acquired a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 1,505,210 shares of the medical device company's stock, valued at approximately $107,939,000. Cooper Companies comprises about 1.4% of Manning & Napier Advisors LLC's portfolio, making the stock its 25th biggest holding. Manning & Napier Advisors LLC owned approximately 0.77% of Cooper Companies at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in COO. BlackRock Inc. bought a new stake in shares of Cooper Companies in the 2nd quarter worth about $1,077,762,000. Generation Investment Management LLP acquired a new stake in shares of Cooper Companies in the 2nd quarter valued at about $356,304,000. Wellington Management Group LLP lifted its position in shares of Cooper Companies by 332.9% during the third quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company's stock worth $424,043,000 after purchasing an additional 4,756,178 shares during the last quarter. Diamond Hill Capital Management Inc. lifted its position in shares of Cooper Companies by 479.6% during the fourth quarter. Diamond Hill Capital Management Inc. now owns 3,287,837 shares of the medical device company's stock worth $269,471,000 after purchasing an additional 2,720,594 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD grew its stake in Cooper Companies by 58.8% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company's stock worth $494,123,000 after purchasing an additional 2,231,568 shares in the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Stock Down 0.6%

Cooper Companies stock opened at $75.80 on Tuesday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The Cooper Companies, Inc. has a one year low of $58.89 and a one year high of $89.83. The company has a 50-day simple moving average of $72.09 and a 200-day simple moving average of $71.07. The firm has a market capitalization of $14.78 billion, a P/E ratio of 64.24, a P/E/G ratio of 1.99 and a beta of 0.83.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, beating the consensus estimate of $1.10 by $0.11. The firm had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. Cooper Companies's quarterly revenue was up 7.9% compared to the same quarter last year. During the same period last year, the firm posted $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, equities analysts expect that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on COO. Wall Street Zen raised Cooper Companies from a "hold" rating to a "buy" rating in a report on Sunday, June 21st. KeyCorp reaffirmed a "sector weight" rating on shares of Cooper Companies in a report on Friday, June 5th. Weiss Ratings lowered Cooper Companies from a "hold (c-)" rating to a "sell (d)" rating in a research report on Monday, June 8th. Wells Fargo & Company reiterated a "sell" rating and issued a $66.00 price target (down from $82.00) on shares of Cooper Companies in a report on Friday, June 5th. Finally, JPMorgan Chase & Co. dropped their price target on Cooper Companies from $80.00 to $71.00 and set a "neutral" rating on the stock in a research report on Friday, June 5th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $81.64.

About Cooper Companies

Cooper Companies, Inc NASDAQ: COO is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women's health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source